164 related articles for article (PubMed ID: 25183203)
1. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial.
Berstad P; Løberg M; Larsen IK; Kalager M; Holme Ø; Botteri E; Bretthauer M; Hoff G
Gut; 2015 Aug; 64(8):1268-76. PubMed ID: 25183203
[TBL] [Abstract][Full Text] [Related]
2. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial.
Larsen IK; Grotmol T; Almendingen K; Hoff G
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):477-83. PubMed ID: 17363335
[TBL] [Abstract][Full Text] [Related]
3. Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia.
Knudsen MD; de Lange T; Botteri E; Nguyen DH; Evensen H; Steen CB; Hoff G; Bernklev T; Hjartåker A; Berstad P
World J Gastroenterol; 2016 Jul; 22(27):6276-86. PubMed ID: 27468217
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
[TBL] [Abstract][Full Text] [Related]
5. Long-term risk of colorectal cancer in individuals with serrated polyps.
Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
[TBL] [Abstract][Full Text] [Related]
6. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial.
Atkin W; Wooldrage K; Parkin DM; Kralj-Hans I; MacRae E; Shah U; Duffy S; Cross AJ
Lancet; 2017 Apr; 389(10076):1299-1311. PubMed ID: 28236467
[TBL] [Abstract][Full Text] [Related]
7. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
8. Assessing generalizability of the findings of sigmoidoscopy screening trials: the case of SCORE trial.
Senore C; Bonelli L; Sciallero S; Casella C; Santarelli A; Armaroli P; Zanetti R; Segnan N
J Natl Cancer Inst; 2015 Jan; 107(1):385. PubMed ID: 25492939
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle in population-based colorectal cancer screening over 2-year follow-up.
Helander S; Heinävaara S; Sarkeala T; Malila N
Eur J Public Health; 2018 Apr; 28(2):333-338. PubMed ID: 29020299
[TBL] [Abstract][Full Text] [Related]
10. Psychological effects of colorectal cancer screening: Participants
Kirkøen B; Berstad P; Botteri E; Bernklev L; El-Safadi B; Hoff G; de Lange T; Bernklev T
World J Gastroenterol; 2016 Nov; 22(43):9631-9641. PubMed ID: 27920484
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle characteristics among participants in a Norwegian colorectal cancer screening trial.
Larsen IK; Grotmol T; Almendingen K; Hoff G
Eur J Cancer Prev; 2006 Feb; 15(1):10-9. PubMed ID: 16374224
[TBL] [Abstract][Full Text] [Related]
12. Changes in health behavior 1 year after testing negative at a colorectal cancer screening: a randomized-controlled study.
Knudsen MD; Hjartåker A; Olsen MKE; Hoff G; de Lange T; Bernklev T; Berstad P
Eur J Cancer Prev; 2018 Jul; 27(4):316-322. PubMed ID: 27824661
[TBL] [Abstract][Full Text] [Related]
13. Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
Doroudi M; Schoen RE; Pinsky PF
Cancer; 2017 Dec; 123(24):4815-4822. PubMed ID: 28976536
[TBL] [Abstract][Full Text] [Related]
14. Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme.
Doria-Rose VP; Levin TR; Palitz A; Conell C; Weiss NS
Gut; 2016 Feb; 65(2):271-7. PubMed ID: 25512639
[TBL] [Abstract][Full Text] [Related]
15. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G
JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129
[TBL] [Abstract][Full Text] [Related]
16. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
Rozen P; Shabtai EI; Liphshitz I; Barchana M
Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
[TBL] [Abstract][Full Text] [Related]
17. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals.
Larsen IK; Grotmol T; Almendingen K; Hoff G
BMC Gastroenterol; 2006 Jan; 6():5. PubMed ID: 16412216
[TBL] [Abstract][Full Text] [Related]
18. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
[TBL] [Abstract][Full Text] [Related]
19. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
20. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.
Doria-Rose VP; Levin TR; Selby JV; Newcomb PA; Richert-Boe KE; Weiss NS
Gastroenterology; 2004 Sep; 127(3):714-22. PubMed ID: 15362026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
